Complete resection is the standard of care for treatment of thymic malignancies. The use of
minimally invasive surgery remains controversial. We searched online databases and …

METHODS This article represents a broad consensus within the ITMIG community, based on
available underlying evidence. A core workgroup assembled data for discussion based on a …

Introduction: Thymic carcinoma is a rare and aggressive thymic neoplasm. The European
Society of Thoracic Surgeons developed a retrospective database collecting patients …

Purpose: Thymomas and thymic carcinomas are rare intrathoracic malignancies that can be
invasive and refractory to conventional treatment. Because these tumors both originate from …

Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas,
or lung metastases) or non-neoplastic conditions (eg, intrathoracic goiter). Thymomas are …

OBJECTIVE: Thymic carcinomas are considered to be more aggressive than thymomas and
carry a worse prognosis. We reviewed our recent experience with the surgical management …

Thymic malignancies are rare tumors of the mediastinum. c-KIT is highly expressed in thymic
carcinomas (TC) but infrequently in thymomas. Anecdotal experience suggests activity of …

This study was conducted to evaluate the prevalence of EGFR and KIT mutations in
thymomas and thymic carcinomas as a means of exploring the potential for molecularly …

Background: Thymic carcinoma (TC) is a rare aggressive tumour. Median survival with
current treatments is only 2 years. Sunitinib is a multi-targeted tyrosine kinase inhibitor that …

Abstract Introduction Thymic epithelial tumors (TETs) are rare tumors originating from the
epithelium of the thymus with limited therapeutic options beyond surgery. The pathogenesis …